About us Timoleon Therapeutics is an early-stage, computational-first company building tumour-selective proximity therapeutics. Were looking for a computational chemist to help us design our first drug candidate, entirely in silico — and then help turn that
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs